Delmont Private Hospital

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Alzheimer disease4 trials
• Frontotemporal dementia1 trial

Phase

• Phase 32 trials
• Phase 21 trial
• Phase 2/31 trial

Status

• Completed3 trials
• Active, not recruiting1 trial

Lead sponsor

• Eli Lilly and Company2 trials
• Anavex Life Sciences Corp.1 trial
• Cassava Sciences, Inc.1 trial

Running trials

• Active, not recruiting

  A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

  NCT04437511· Phase 3· Eli Lilly and Company· Source

Closed trials

• Completed

  Simufilam 100 mg for Mild-to-Moderate Alzheimer's Disease

  NCT04994483· Phase 3· Cassava Sciences, Inc.· Source

• Completed

  A Study of LY3372689 to Assess the Safety, Tolerability, and Efficacy in Participants With Alzheimer's Disease

  NCT05063539· Phase 2· Eli Lilly and Company· Source

• Completed

  OLE of Phase 2b/3 Study ANAVEX2-73-AD-004

  NCT04314934· Phase 2/3· Anavex Life Sciences Corp.· Source